This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zuckerman T, Beyar-Katz O, Rowe JM . Should autotransplantation in acute myeloid leukemia in first complete remission be revisited? Curr Opin Hematol 2016; 23: 88–94.
Gorin NC, Giebel S, Labopin M, Savani BN, Mohty M, Nagler A . Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects. Bone Marrow Transplant 2015; 50: 1495–1502.
Vellenga E, van Putten W, Ossenkoppele GJ, Verdonck LF, Theobald M, Cornelissen JJ et al. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood 2011; 118: 6037–6042.
Bik To L, Levesque JP, Herbert KE . How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011; 118: 4530–4540.
Stölzel F, Wermke M, Röllig C, Thiede C, Platzbecker U, Bornhäuser M . Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxide. Haematologica 2010; 95: 171–172.
Bargetzi MJ, Passweg J, Baertschi E, Schoenenberger A, Gwerder C, Tichelli A et al. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective. Bone Marrow Transplant 2003; 31: 99–103.
Heizmann M, O'Meara AC, Moosmann PR, Heijnen IA, Zuberbühler M, Fernandez P et al. Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma. Bone Marrow Transplant 2009; 44: 75–79.
Schmid A, Friess D, Mansouri Taleghani B, Keller P, Mueller BU, Baerlocher GM et al. Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial). Leuk Lymphoma 2015; 56: 608–614.
Keller S, Seipel K, Novak U, Mueller BU, Taleghani BM, Leibundgut K et al. Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment. Leuk Res 2015; 39: 786–792.
Von Grunigen I, Raschle J, Rusges-Wolter I, Mansouri Taleghani BM, Mueller BU, Pabst T . The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential. Leuk Res 2012; 36: 1325–1329.
Wetzel D, Mueller BU, Mansouri Taleghani B, Baerlocher GM, Seipel K, Leibundgut K et al. Delayed haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia. Br J Haematol 2015; 168: 268–273.
Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P et al. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Bone Marrow Transplant 1999; 24: 467–472.
Breems DA, Lowenberg B . Acute myeloid leukemia and the position of autologous stem cell transplantation. Semin Hematol 2007; 44: 259–266.
Cornelissen JJ, Versluis J, Passweg JR, van Putten WL, Manz MG, Maertens J et al. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia 2015; 29: 1041–1050.
Wang J, Ouyang J, Zhou R, Chen B, Yang Y . Autologous hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trials. Acta Haematol 2010; 124: 61–71.
Acknowledgements
We thank the stem cell coordinating team, the stem cell data-management team, the members of the stem cell collection unit and members of the stem cell processing unit associated with the stem cell program at the University Hospital Berne for providing the data used in this analysis. Also, we thank all staff members involved in the care of the patients reported in this study. This study was supported by grants SNF-310030-143584 to TP.
Author contributions
VB performed the research, analyzed the data and wrote the paper; AH performed the research, analyzed the data, reviewed the manuscript and was involved in the final writing of the paper; KS analyzed the data, reviewed the manuscript and was involved in the final writing of the paper; BMT, GMB, UN, KL, YB and MB contributed relevant data, reviewed the manuscript and were involved in the final writing of the paper; and TP designed the research, analyzed the data and wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Blum, V., Heini, A., Novak, U. et al. Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML. Bone Marrow Transplant 52, 786–788 (2017). https://doi.org/10.1038/bmt.2017.2
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.2